Chemical Compound
MDL 28170; Carbamic acid, N-[(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester; Carbamic acid, [(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester (9CI); Calp III; Calpain Inhibitor III; MDL 2817
CAS Registry Number
88191-84-8
Primary record
MDL 28170; Carbamic acid, N-[(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester; Carbamic acid, [(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester (9CI); Calp III; Calpain Inhibitor III; MDL 2817
- 库存
- 9,314 克
- 纯度
- 99.7 %
- CAS
- 88191-84-8
化合物标识与属性
- CAS
- 88191-84-8
- PubChem CID
- 11199915
- SMILES
- CC(C)[C@@H](C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2
- Canonical SMILES
- CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1
名称与同义词
- Calpain Inhibitor III
- Cbz-valpheh
- MDL 28170
- Cbz-val-phe-H
- N-Cbz-val-phe-al
- 88191-84-8
- MDL-28170
- Carbobenzoxy-valinyl-phenylalaninal
- RefChem:1095054
- UNII-WCJ9LQ197S
- CHEMBL423112
- MDL28170
- MLS002153523
- SCHEMBL8537196
- C22H26N2O4
- Calpain Inhibitor III, MDL 28170
- HMS2230F11
- EX-A2237
- MDL28170; Calpain Inhibitor III
- BDBM50073850
- MFCD28137700
- N-Benzyloxycarbonylvalylphenylalaninal
- Carbobenzoxyvalylphenylalanine aldehyde
- AKOS024456416
- C22-H26-N2-O4
- CCG-207847
- CID11199915
- BC600727
- DA-62013
- HY-18236
- SMR001230853
- A4412
- CS-0007315
- N-Benzyloxycarbonylvalylphenylalanine aldehyde
- S7394
- Calpain Inhibitor III - CAS 88191-84-8
- MDL 28170, >=95% (HPLC)
- E78204
- benzyl N-[(2s)-3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]carbamate
- N-[N-[(Phenylmethoxy)carbonyl]-L-valyl]-phenylalaninal
- (S)-2-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-phenyl-propionic acid
- [(S)-1-(1-Benzyl-2-oxo-ethylcarbamoyl)-2-methyl-propyl]-carbamic acid benzyl ester
- [1-(1-Benzyl-2-oxo-ethylcarbamoyl)-2-methyl-propyl]-carbamic acid benzyl ester
- [1-(1-Formyl-2-phenyl-ethylcarbamoyl)-2-methyl-propyl]-carbamic acid benzyl ester
- Benzyl ((2S)-3-methyl-1-oxo-1-((1-oxo-3-phenylpropan-2-yl)amino)butan-2-yl)carbamate
- Benzyl ((S)-3-methyl-1-oxo-1-(((S)-1-oxo-3-phenylpropan-2-yl)amino)butan-2-yl)carbamate
- benzyl (2S)-3-methyl-1-oxo-1-(1-oxo-3-phenylpropan-2-ylamino)butan-2-ylcarbamate
- benzyl (S)-3-methyl-1-oxo-1-(1-oxo-3-phenylpropan-2-ylamino)butan-2-ylcarbamate
- benzyl N-[(1S)-1-[(1-benzyl-2-oxo-ethyl)carbamoyl]-2-methyl-propyl]carbamate
- benzyl N-[(1S)-2-methyl-1-[(1-oxo-3-phenylpropan-2-yl)carbamoyl]propyl]carbamate
- Phenylmethyl N-((1S)-1-(((1-formyl-2-phenylethyl)amino)carbonyl)-2-methylpropyl)carbamate
- MDL 28170; Carbamic acid, N-[(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester; Carbamic acid, [(1S)-1-[[(1-formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester (9CI); Calp III; Calpain Inhibitor III; MDL 2817
- N-[(1S)-1-[[(1-Formyl-2-phenylethyl)amino]carbonyl]-2-methylpropyl]carbamic acid phenylmethyl ester
- Phenylmethyl ((1S)-1-((((1S)-1-formyl-2-phenylethyl)amino)carbonyl)-2-methylpropyl)carbamate